Renerva develops implantable technologies designed to enhance the outcomes of peripheral nerve repair procedures, facilitating faster healing and improved functional recovery. The company addresses the challenges faced by patients with nerve injuries by providing solutions that restore nerve function and quality of life.
Funding
$996.2K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Peripheral nerve injuries often result in incomplete or slow healing, leading to suboptimal functional recovery for patients. Current surgical repair techniques can be limited in their ability to fully restore nerve function and improve the patient's quality of life.
Solution
Renerva is developing implantable medical devices designed to enhance peripheral nerve repair outcomes, accelerating healing and improving functional recovery. Their technology aims to address the limitations of existing nerve repair procedures by providing a solution that supports nerve regeneration and restoration of function. The company focuses on creating innovative surgical solutions that promote nerve recovery and offer hope for patients seeking to regain a good quality of life after nerve injuries.
Target Audience
The primary target audience includes surgeons specializing in peripheral nerve repair and patients who have suffered nerve injuries.
Features
- Implantable technology to support peripheral nerve regeneration
- Designed to improve outcomes of nerve repair procedures
- Focus on accelerating healing and functional recovery